Matthew Segall's Biography

Matthew Segall, Chief Executive Officer, Optibrium Ltd

Dr Matthew Segall has a BA in physics and MSc in computation from the University of Oxford and a Ph.D. from the University of Cambridge. As Associate Director at Camitro, ArQule and then Inpharmatica, he led a team developing predictive ADME and decision-support tools for drug discovery. In 2006 he became responsible for Inpharmatica's ADME group and then, following acquisition, BioFocus's ADMET division. In 2009 Matt led a management buyout of the StarDrop software business from BioFocus to found Optibrium.